tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (DE:8E8)
:8E8
Germany Market

Elicera Therapeutics AB (8E8) Income Statement

Compare
0 Followers

Elicera Therapeutics AB Income Statement

Last quarter (Q4 2024), Elicera Therapeutics AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q4, Elicera Therapeutics AB's net income was kr-2.60M. See Elicera Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 7.13Mkr 11.23Mkr 1.28Mkr 587.00kr 0.00
Gross Profit
kr 7.13Mkr 11.22Mkr 1.27Mkr -11.19Kkr -11.78K
Operating Expenses
kr 24.01Mkr 28.33Mkr 19.36Mkr 13.12Mkr 2.83M
Depreciation and Amortization
kr 11.78Kkr 11.78Kkr 11.78Kkr 11.78Kkr 11.78K
EBITDA
kr -16.82Mkr -17.08Mkr -19.43Mkr -13.11Mkr -2.82M
Operating Income
kr -16.88Mkr -17.10Mkr -19.36Mkr -13.12Mkr -2.83M
Other Income/Expenses
kr 773.73Kkr 698.30Kkr -75.88Kkr -1.07Kkr 5.42K
Pretax Income
kr -16.11Mkr -16.40Mkr -19.44Mkr -13.12Mkr -2.82M
Net Income
kr -16.11Mkr -16.40Mkr -19.51Mkr -13.12Mkr -2.82M
Per Share Metrics
Basic EPS
kr -0.51kr -0.83kr -0.99kr -0.82kr -0.23
Diluted EPS
kr -0.51kr -0.83kr -0.99kr -0.82kr -0.23
Weighted Average Shares Outstanding
31.57M 19.78M 19.78M 15.94M 12.03M
Weighted Average Shares Outstanding (Diluted)
31.57M 19.78M 19.78M 15.94M 12.03M
Currency in SEK

Elicera Therapeutics AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis